Loading data
DAONYSE
| Unit: USD | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | 844.98 m USD | 770.75 m USD | 759.05 m USD | 726.84 m USD |
| Cost of revenue | 470.78 m USD | 394.21 m USD | 369.27 m USD | 351.85 m USD |
| Gross profit | 374.2 m USD | 376.54 m USD | 389.79 m USD | 375 m USD |
| Research and development expense | 73.54 m USD | 73.98 m USD | 104.7 m USD | 116.54 m USD |
| Operating profit | 31.65 m USD | 20.39 m USD | -65.68 m USD | -112.32 m USD |
| Interest expense | 9.01 m USD | 10.01 m USD | 9.79 m USD | 6.61 m USD |
| Profit before tax | 16.25 m USD | 11.13 m USD | -75.92 m USD | -105.25 m USD |
| Income tax expense | 2.37 m USD | 823 k USD | 1.56 m USD | 2.01 m USD |
| Net income (reported basis) | 13.88 m USD | 10.31 m USD | -77.48 m USD | -108.14 m USD |
| Net income attributable to common shareholders | 15.35 m USD | 11.26 m USD | -77.46 m USD | -105.41 m USD |
| Basic earnings per share | 0.13 USD/share | 0.1 USD/share | -0.64 USD/share | -0.85 USD/share |
| Diluted earnings per share | 0.13 USD/share | 0.1 USD/share | -0.64 USD/share | -0.85 USD/share |
Quotes are end-of-day data. Content is for research purposes and is not investment advice.